scispace - formally typeset
H

H.L. Bock

Researcher at GlaxoSmithKline

Publications -  11
Citations -  1274

H.L. Bock is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Vaccination & Reactogenicity. The author has an hindex of 10, co-authored 11 publications receiving 1114 citations.

Papers
More filters
Journal ArticleDOI

Evaluation of RIX4414, A Live, Attenuated Rotavirus Vaccine, in a Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial Involving 2464 Singaporean Infants

TL;DR: The live, attenuated rotavirus vaccine (RIX4414) was well tolerated and highly immunogenic in Singaporean infants and the immunogenicity of routinely administered infant vaccines was not impaired by concomitant administration of RIX4414.
Journal ArticleDOI

Survey of childhood empyema in Asia: Implications for detecting the unmeasured burden of culture-negative bacterial disease

TL;DR: The age and gender distribution of empyema and pleural effusion in children in these countries are similar to the US and Western Europe, which suggests that culture may not be a sufficiently sensitive diagnostic method to determine etiology in the majority of cases.

Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease.

TL;DR: Wang et al. as mentioned in this paper surveyed medical records of four representative large pediatric hospitals in China, Korea, Taiwan and Vietnam using ICD-10 diagnostic codes to identify children <16 years of age hospitalized with empyema or pleural effusion from 1995 to 2005.